Search hospitals > South Carolina > Charleston
Charleston Hematology Oncology Associates, PA
Claim this profileCharleston, South Carolina 29414
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Leukemia
107 reported clinical trials
2 medical researchers
Summary
Charleston Hematology Oncology Associates, PA is a medical facility located in Charleston, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Leukemia and other specialties. Charleston Hematology Oncology Associates, PA is involved with conducting 107 clinical trials across 69 conditions. There are 2 research doctors associated with this hospital, such as Brian Lingerfelt, MD and David Ellison.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
Stage III
2Lung Cancer
Global LeaderStage III
Stage IV
PD-L1 positive
Top PIs
Brian Lingerfelt, MDCharleston Oncology4 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
3 reported clinical trials
4 drugs studied
David EllisonCharleston Hematology Oncology Associates CHOA2 years of reported clinical research
Studies Prostate Cancer
Studies Breast Cancer
3 reported clinical trials
9 drugs studied
Clinical Trials running at Charleston Hematology Oncology Associates, PA
Cancer
Multiple Myeloma
Breast Cancer
Plasma Cell Neoplasms
Recurrence
Tumors
Continued Darolutamide Treatment
for Cancer
This trial continues darolutamide treatment for patients who were part of a previous study and are believed to benefit from it. Darolutamide helps by blocking hormones that can make cancer cells grow. Patients will keep taking the same dosage and visit their doctors regularly. Darolutamide has been shown to slow cancer spread and improve survival in patients with nonmetastatic castration-resistant prostate cancer.
Recruiting2 awards Phase 34 criteria
MRTX849
for Cancer
This trial is testing a new pill called MRTX849 (adagrasib) for patients with advanced cancers that have a specific genetic change called KRAS G12C. The pill aims to block this change and stop the cancer from growing. Adagrasib is similar to another approved treatment and is intended for patients with this genetic change who have already received other treatments.
Recruiting1 award Phase 1 & 24 criteria
Nivolumab Safety
for Cancer
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Charleston Hematology Oncology Associates, PA?
Charleston Hematology Oncology Associates, PA is a medical facility located in Charleston, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Leukemia and other specialties. Charleston Hematology Oncology Associates, PA is involved with conducting 107 clinical trials across 69 conditions. There are 2 research doctors associated with this hospital, such as Brian Lingerfelt, MD and David Ellison.